| R’000 |
Number of
shares
(’000) |
Share
capital
(Note 8) |
Share
premium
(Note 8) |
Non-
distributable
reserve
(Note 9) |
Distributable
reserve |
Total |
| Balance at 31 August 2001 |
298 541 |
2 985 |
494 570 |
94 808 |
423 170 |
1 015 533 |
| Capitalisation awards |
3 549 |
36 |
25 767 |
– |
– |
25 803 |
| Shares issued in respect of options |
3 082 |
31 |
14 118 |
– |
– |
14 149 |
| Foreign currency translation reserve |
|
– |
– |
83 611 |
– |
83 611 |
| Deferred tax on write-off of intangible assets |
|
– |
– |
(9 300) |
9 300 |
– |
| Profit for the year |
|
– |
– |
– |
146 200 |
146 200 |
| Distributions |
|
– |
– |
– |
(63 539) |
(63 539) |
| Balance at 31 August 2002 |
305 172 |
3 052 |
534 455 |
169 119 |
515 131 |
1 221 757 |
| Capitalisation awards |
6 165 |
62 |
37 300 |
– |
– |
37 362 |
| Shares issued in respect of options |
1 933 |
19 |
9 753 |
– |
– |
9 772 |
| Share issue expenses written off |
|
– |
(1 053) |
– |
– |
(1 053) |
| Acquisition of New United Pharmaceutical |
|
|
|
|
|
|
| Distributors |
40 848 |
408 293 |
698 |
– |
– |
294 106 |
| Foreign currency translation reserve |
|
– |
– |
(86 097) |
– |
(86 097) |
| Deferred tax on write-off of intangible assets |
|
– |
– |
(9 300) |
9 300 |
– |
| Profit for the year |
|
– |
– |
– |
214 268 |
214 268 |
| Distributions |
|
– |
– |
– |
(81 605) |
(81 605) |
| Balance
at 31 August 2003 |
354 118 |
3 541 |
874 153 |
73 722 |
657 094 |
1 608 510 |
